首页 > 最新文献

Future medicinal chemistry最新文献

英文 中文
Current landscape of tropomyosin receptor tyrosine kinase inhibitors.
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-26 DOI: 10.1080/17568919.2024.2403968
Hala B El-Nassan
{"title":"Current landscape of tropomyosin receptor tyrosine kinase inhibitors.","authors":"Hala B El-Nassan","doi":"10.1080/17568919.2024.2403968","DOIUrl":"https://doi.org/10.1080/17568919.2024.2403968","url":null,"abstract":"","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme.
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-24 DOI: 10.1080/17568919.2024.2400982
Hemanathan Elango, Rabindra Nath Das, Abhijit Saha

Telomeres, crucial for chromosomal integrity, have been related to aging and cancer formation, mainly through regulating G-quadruplex structures. G-quadruplexes are structural motifs that can arise as secondary structures of nucleic acids, especially in guanine-rich DNA and RNA regions. Targeting these structures by small compounds shows promise in the selective suppression of cell growth, opening up novel possibilities for anticancer treatment. A comprehensive investigation of the many structural forms of G-quadruplex ligands is required to create ground-breaking anticancer drugs. Recent research into using specific benzimidazole molecules in stabilizing telomeric DNA into G-quadruplex structures has highlighted their ability to influence oncogene expression and demonstrate antiproliferative characteristics against cancer cells. This review describes the benzimidazole derivative, designed to enhance the stability of the G-quadruplex structure DNA to suppress the activity of telomerase enzyme, exhibiting promising potential for anticancer therapy.

端粒对染色体的完整性至关重要,它与衰老和癌症的形成有关,主要是通过调节 G 型四联体结构来实现的。G 型四联体是核酸的二级结构,尤其是在富含鸟嘌呤的 DNA 和 RNA 区域。用小分子化合物靶向这些结构有望选择性地抑制细胞生长,为抗癌治疗提供了新的可能性。要研制出突破性的抗癌药物,就必须对 G-四叠体配体的多种结构形式进行全面研究。最近对使用特定苯并咪唑分子将端粒 DNA 稳定为 G-四联体结构的研究突出表明,它们能够影响癌基因的表达,并显示出对癌细胞的抗增殖特性。本综述介绍了苯并咪唑衍生物,这种衍生物旨在增强 G 型四联结构 DNA 的稳定性,从而抑制端粒酶的活性,在抗癌治疗方面具有广阔的前景。
{"title":"Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme.","authors":"Hemanathan Elango, Rabindra Nath Das, Abhijit Saha","doi":"10.1080/17568919.2024.2400982","DOIUrl":"https://doi.org/10.1080/17568919.2024.2400982","url":null,"abstract":"<p><p>Telomeres, crucial for chromosomal integrity, have been related to aging and cancer formation, mainly through regulating G-quadruplex structures. G-quadruplexes are structural motifs that can arise as secondary structures of nucleic acids, especially in guanine-rich DNA and RNA regions. Targeting these structures by small compounds shows promise in the selective suppression of cell growth, opening up novel possibilities for anticancer treatment. A comprehensive investigation of the many structural forms of G-quadruplex ligands is required to create ground-breaking anticancer drugs. Recent research into using specific benzimidazole molecules in stabilizing telomeric DNA into G-quadruplex structures has highlighted their ability to influence oncogene expression and demonstrate antiproliferative characteristics against cancer cells. This review describes the benzimidazole derivative, designed to enhance the stability of the G-quadruplex structure DNA to suppress the activity of telomerase enzyme, exhibiting promising potential for anticancer therapy.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Organotellurium (IV) complexes as anti-malarial agents: synthesis, characterization and computational insights. 作为抗疟疾剂的有机碲(IV)复合物:合成、表征和计算见解。
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-23 DOI: 10.1080/17568919.2024.2401310
Anisha Bhardwaj, Amit Dubey, Aisha Tufail, Nasir Tufail, Manish Kumar, Sapana Garg

Aim: To synthesize and evaluate the antimalarial and antioxidant activities of novel organotellurium (IV) thiophene-based complexes.Materials & methods: Synthesized complexes were characterized using NMR, IR and mass spectrometry. Their biological activities were assessed using in vitro assays and molecular docking studies.Results: The complexes exhibited significant antimalarial activity against Plasmodium falciparum, with the highest activity observed for complexes 5b and 5e. ADMET properties confirmed their potential as therapeutic agents.

目的:合成并评估新型有机碲(IV)噻吩基复合物的抗疟和抗氧化活性:使用核磁共振、红外和质谱对合成的复合物进行表征。材料与方法:利用核磁共振、红外光谱和质谱对合成的复合物进行了表征,并利用体外试验和分子对接研究对其生物活性进行了评估:结果:复合物对恶性疟原虫具有明显的抗疟活性,其中复合物 5b 和 5e 的活性最高。ADMET 特性证实了它们作为治疗剂的潜力。
{"title":"Organotellurium (IV) complexes as anti-malarial agents: synthesis, characterization and computational insights.","authors":"Anisha Bhardwaj, Amit Dubey, Aisha Tufail, Nasir Tufail, Manish Kumar, Sapana Garg","doi":"10.1080/17568919.2024.2401310","DOIUrl":"https://doi.org/10.1080/17568919.2024.2401310","url":null,"abstract":"<p><p><b>Aim:</b> To synthesize and evaluate the antimalarial and antioxidant activities of novel organotellurium (IV) thiophene-based complexes.<b>Materials & methods:</b> Synthesized complexes were characterized using NMR, IR and mass spectrometry. Their biological activities were assessed using <i>in vitro</i> assays and molecular docking studies.<b>Results:</b> The complexes exhibited significant antimalarial activity against <i>Plasmodium falciparum</i>, with the highest activity observed for complexes 5b and 5e. ADMET properties confirmed their potential as therapeutic agents.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel benzimidazole-based azine derivatives as potent urease inhibitors: synthesis, in vitro and in silico approach. 作为强效脲酶抑制剂的新型苯并咪唑基嗪衍生物:合成、体外和硅学方法。
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-23 DOI: 10.1080/17568919.2024.2401311
Hamidullah, Aftab Alam, Ahmed A Elhenawy, Mumtaz Ali, Abdul Latif, Ajmal Khan, Ahmed Al-Harrasi, Manzoor Ahmad

Aim: In light of various biological activities of benzimidazole and azines, this study focuses on reporting novel derivatives of benzimidazole nucleus.Methods: Twenty novel azines of benzimidazole were synthesized, characterized and tested for in vitro urease inhibitory activity.Results: All these derivatives showed excellent to good inhibition in the range of IC50 values 14.21 ± 1.87 to 76.11 ± 1.81 μM by comparing with standard thiourea 21.14 ± 0.42 μM. Docking studies were performed for the targeted benzimidazole derivatives to understand the binding mechanics. The results indicated higher binding efficacy compared with the reference inhibitor.Conclusion: This work identifies potential lead candidates for novel urease inhibitors, which with industrial support may be harnessed for the development of new drugs.

目的:鉴于苯并咪唑和叠氮的各种生物活性,本研究重点报道了苯并咪唑核的新型衍生物:方法:对 20 种新型苯并咪唑叠氮化物进行了合成、表征和体外脲酶抑制活性测试:结果:与标准硫脲 21.14 ± 0.42 μM 相比,所有这些衍生物都表现出极好的抑制作用,IC50 值范围在 14.21 ± 1.87 到 76.11 ± 1.81 μM 之间。对目标苯并咪唑衍生物进行了 Docking 研究,以了解其结合机理。结果表明,与参考抑制剂相比,苯并咪唑衍生物具有更高的结合效力:本研究发现了新型脲酶抑制剂的潜在候选先导化合物,在工业界的支持下可用于新药开发。
{"title":"Novel benzimidazole-based azine derivatives as potent urease inhibitors: synthesis, <i>in vitro</i> and <i>in silico</i> approach.","authors":"Hamidullah, Aftab Alam, Ahmed A Elhenawy, Mumtaz Ali, Abdul Latif, Ajmal Khan, Ahmed Al-Harrasi, Manzoor Ahmad","doi":"10.1080/17568919.2024.2401311","DOIUrl":"https://doi.org/10.1080/17568919.2024.2401311","url":null,"abstract":"<p><p><b>Aim:</b> In light of various biological activities of benzimidazole and azines, this study focuses on reporting novel derivatives of benzimidazole nucleus.<b>Methods:</b> Twenty novel azines of benzimidazole were synthesized, characterized and tested for <i>in vitro</i> urease inhibitory activity.<b>Results:</b> All these derivatives showed excellent to good inhibition in the range of IC<sub>50</sub> values 14.21 ± 1.87 to 76.11 ± 1.81 μM by comparing with standard thiourea 21.14 ± 0.42 μM. Docking studies were performed for the targeted benzimidazole derivatives to understand the binding mechanics. The results indicated higher binding efficacy compared with the reference inhibitor.<b>Conclusion:</b> This work identifies potential lead candidates for novel urease inhibitors, which with industrial support may be harnessed for the development of new drugs.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring biological activities of novel Schiff bases derived from amlodipine and in silico molecular modeling studies. 探索由氨氯地平衍生的新型希夫碱的生物活性并进行硅学分子建模研究。
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-20 DOI: 10.1080/17568919.2024.2401313
Anum Masood, Mohsin Abbas Khan, Mashooq A Bhat, Breena Awan, Ramsha Hanif, Asim Raza, Saharish Khaliq, Javaid Ahmed, Farhat Ullah

Aim: Calcium channel antagonists are of considerable interest in treating elevated blood pressure and its pathologies.Materials & methods: Schiff base derivatives of amlodipine were produced to check its urease inhibition potentials as well antibacterial and antioxidant activities. Structural illustration along with chemical characterization were achieved by spectral techniques (1H NMR, FTIR, 13C NMR) and docking studies also performed.Results & conclusion: 3g displayed remarkable anti-hypertensive activity compared with parent drug. 3b, 3f and 3g showed urease inhibition potentials. These compounds can aid as lead for further investigations since they exhibited comparable or superior interactions.

材料与方法:制备了氨氯地平的希夫碱衍生物,以检测其脲酶抑制潜力以及抗菌和抗氧化活性。结果与结论:与母药相比,3g 具有显著的抗高血压活性。3b、3f 和 3g 具有抑制脲酶的潜力。由于这些化合物表现出相似或更优越的相互作用,因此可以作为进一步研究的线索。
{"title":"Exploring biological activities of novel Schiff bases derived from amlodipine and <i>in silico</i> molecular modeling studies.","authors":"Anum Masood, Mohsin Abbas Khan, Mashooq A Bhat, Breena Awan, Ramsha Hanif, Asim Raza, Saharish Khaliq, Javaid Ahmed, Farhat Ullah","doi":"10.1080/17568919.2024.2401313","DOIUrl":"https://doi.org/10.1080/17568919.2024.2401313","url":null,"abstract":"<p><p><b>Aim:</b> Calcium channel antagonists are of considerable interest in treating elevated blood pressure and its pathologies.<b>Materials & methods:</b> Schiff base derivatives of amlodipine were produced to check its urease inhibition potentials as well antibacterial and antioxidant activities. Structural illustration along with chemical characterization were achieved by spectral techniques (<sup>1</sup>H NMR, FTIR, <sup>13</sup>C NMR) and docking studies also performed.<b>Results & conclusion:</b> 3g displayed remarkable anti-hypertensive activity compared with parent drug. 3b, 3f and 3g showed urease inhibition potentials. These compounds can aid as lead for further investigations since they exhibited comparable or superior interactions.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763. 一种水溶性低影响安帕金原药 CX1942 及其活性分子 CX1763 的临床前特征。
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-20 DOI: 10.1080/17568919.2024.2401312
Daniel P Radin, Sheng Zhong, Rok Cerne, Mohammed Shoaib, Jeffrey M Witkin, Arnold Lippa

Aim: AMPA-glutamate receptor (AMPAR) dysfunction mediates multiple neurological/neuropsychiatric disorders. Ampakines bind AMPARs and allosterically enhance glutamate-elicited currents. This report describes the activity of the water-soluble ampakine CX1942 prodrug and the active moiety CX1763.Results: CX1763 and CX1942 enhance synaptic transmission in hippocampi of rats. CX1763 increases attention in the 5CSRTT in rats and reduces amphetamine-induced hyperactivity in mice. CX1942 potently reverses opioid-induced respiratory depression in rats. CX1942/CX1763 was effective at 2.5-10 mg/kg. CX1763 lacked epileptogenicity up to 1500 mg/kg in rats.Conclusion: These data document that CX1942 and CX1763 are active and without prominent side effects in multiple pre-clinical assays. CX1942 could serve as a prodrug for CX1763 with the advantage of high water solubility as in an intravenous formulation.

目的:AMPA-谷氨酸受体(AMPAR)功能障碍介导多种神经/神经精神疾病。安非他明类药物能与 AMPAR 结合,并通过异体作用增强谷氨酸诱导的电流。本报告介绍了水溶性安帕金 CX1942 原药和活性分子 CX1763 的活性:结果:CX1763 和 CX1942 能增强大鼠海马的突触传递。CX1763 可提高大鼠 5CSRTT 的注意力,减少苯丙胺诱导的小鼠多动症。CX1942 能有效逆转阿片诱导的大鼠呼吸抑制。CX1942/CX1763 的有效剂量为 2.5-10 毫克/千克。CX1763 对大鼠的致痫性可达 1500 毫克/千克:这些数据表明,CX1942 和 CX1763 在多种临床前试验中具有活性,且无明显副作用。CX1942 可作为 CX1763 的原药,在静脉注射制剂中具有高水溶性的优势。
{"title":"Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763.","authors":"Daniel P Radin, Sheng Zhong, Rok Cerne, Mohammed Shoaib, Jeffrey M Witkin, Arnold Lippa","doi":"10.1080/17568919.2024.2401312","DOIUrl":"https://doi.org/10.1080/17568919.2024.2401312","url":null,"abstract":"<p><p><b>Aim:</b> AMPA-glutamate receptor (AMPAR) dysfunction mediates multiple neurological/neuropsychiatric disorders. Ampakines bind AMPARs and allosterically enhance glutamate-elicited currents. This report describes the activity of the water-soluble ampakine CX1942 prodrug and the active moiety CX1763.<b>Results:</b> CX1763 and CX1942 enhance synaptic transmission in hippocampi of rats. CX1763 increases attention in the 5CSRTT in rats and reduces amphetamine-induced hyperactivity in mice. CX1942 potently reverses opioid-induced respiratory depression in rats. CX1942/CX1763 was effective at 2.5-10 mg/kg. CX1763 lacked epileptogenicity up to 1500 mg/kg in rats.<b>Conclusion:</b> These data document that CX1942 and CX1763 are active and without prominent side effects in multiple pre-clinical assays. CX1942 could serve as a prodrug for CX1763 with the advantage of high water solubility as in an intravenous formulation.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Naphthoquinone fused diazepines targeting hyperamylasemia: potential therapeutic agents for diabetes and cancer. 针对高淀粉酶血症的萘醌融合二氮杂卓:糖尿病和癌症的潜在治疗药物。
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-20 DOI: 10.1080/17568919.2024.2400968
Sandhya Chahal, Payal Rani, Rajvir Singh, Gaurav Joshi, Roshan Kumar, Parvin Kumar, Deepak Wadhwa, Devender Singh, Jayant Sindhu

Aim: Elevated levels of amylase in the blood, known as hyperamylasemia, have been correlated with diabetes and cancer. To investigate the impact of hyperamylasemia on cellular proliferation, it is imperative to design dual inhibitors targeting both α-amylase activity and cancer progression.Materials & methods: Naphthoquinone fused diazepines have been synthesized using multicomponent reaction with high Eco-score of 87 and evaluated for bio efficacy using antioxidant and α-amylase inhibition assay. A correlation between diabetes and cancer has been established via preliminary screening against A549 based lung cancer cell line at 5 μM.Results & conclusion: Compound 4b exhibited superior anti-oxidant and α-amylase inhibitory potential over butylated hydroxytoluene (BHT) and acarbose, respectively with uncompetitive mode of inhibition. Compounds possessing more than 50 % inhibition were then investigated for their IC50 against A549 (Lung cancer), and Breast cancer (MCF-7 and MDA-MB-231) cells. Among all, compound 4p has been selected for further studies, as it demonstrated significant cytotoxicity, while compound 4b showed no effect on AKT gene expression but upregulated IGF-1R gene expression, suggesting a role in managing diabetes. Compound 4p exhibited the ability to decrease AKT expression and increase IGF-1R expression, indicating its potential for treating both diabetes and cancer.

目的:血液中淀粉酶水平升高(称为高淀粉血症)与糖尿病和癌症有关。为了研究高淀粉酶血症对细胞增殖的影响,必须设计同时针对α-淀粉酶活性和癌症进展的双重抑制剂:通过多组分反应合成了萘醌融合二氮杂卓,其生态分数高达 87,并通过抗氧化和α-淀粉酶抑制实验评估了其生物功效。通过对 5 μM 的 A549 肺癌细胞系进行初步筛选,确定了糖尿病与癌症之间的相关性:化合物 4b 的抗氧化性和抑制α-淀粉酶的潜力分别优于丁基化羟基甲苯(BHT)和阿卡波糖,且具有非竞争性抑制模式。然后研究了抑制率超过 50% 的化合物对 A549(肺癌)和乳腺癌(MCF-7 和 MDA-MB-231)细胞的 IC50。化合物 4b 对 AKT 基因的表达没有影响,但能上调 IGF-1R 基因的表达,这表明它能在控制糖尿病方面发挥作用。化合物 4p 显示出降低 AKT 表达和提高 IGF-1R 表达的能力,表明其具有治疗糖尿病和癌症的潜力。
{"title":"Naphthoquinone fused diazepines targeting hyperamylasemia: potential therapeutic agents for diabetes and cancer.","authors":"Sandhya Chahal, Payal Rani, Rajvir Singh, Gaurav Joshi, Roshan Kumar, Parvin Kumar, Deepak Wadhwa, Devender Singh, Jayant Sindhu","doi":"10.1080/17568919.2024.2400968","DOIUrl":"https://doi.org/10.1080/17568919.2024.2400968","url":null,"abstract":"<p><p><b>Aim:</b> Elevated levels of amylase in the blood, known as hyperamylasemia, have been correlated with diabetes and cancer. To investigate the impact of hyperamylasemia on cellular proliferation, it is imperative to design dual inhibitors targeting both α-amylase activity and cancer progression.<b>Materials & methods:</b> Naphthoquinone fused diazepines have been synthesized using multicomponent reaction with high Eco-score of 87 and evaluated for bio efficacy using antioxidant and α-amylase inhibition assay. A correlation between diabetes and cancer has been established <i>via</i> preliminary screening against A549 based lung cancer cell line at 5 μM.<b>Results & conclusion:</b> Compound <b>4b</b> exhibited superior anti-oxidant and α-amylase inhibitory potential over butylated hydroxytoluene (BHT) and acarbose, respectively with uncompetitive mode of inhibition. Compounds possessing more than 50 % inhibition were then investigated for their IC<sub>50</sub> against A549 (Lung cancer), and Breast cancer (MCF-7 and MDA-MB-231) cells. Among all, compound <b>4p</b> has been selected for further studies, as it demonstrated significant cytotoxicity, while compound <b>4b</b> showed no effect on <i>AKT</i> gene expression but upregulated <i>IGF-1R</i> gene expression, suggesting a role in managing diabetes. Compound <b>4p</b> exhibited the ability to decrease <i>AKT</i> expression and increase <i>IGF-1R</i> expression, indicating its potential for treating both diabetes and cancer.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasonic-assisted synthesis and antitumor evaluation of novel variant heterocyclic compounds based on piperidine ring. 基于哌啶环的新型变异杂环化合物的超声波辅助合成及抗肿瘤评价。
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-20 DOI: 10.1080/17568919.2024.2385295
Asmaa Aboelnaga, Eman El-Sayed Ebead, Ekhlass Nassar, Mohamed M Naguib, Mahmoud F Ismail

Aim: This work explores the eco-friendly synthesis of various heterocycles from a piperidine-based compound (1) and explore their potential as antitumor agents.Materials & methods: Ultrasonic irradiation was used to synthesize heterocycles like pyridone, thiophene and coumarin, with computational tools analyzing stability and biological interactions.Results: Compounds 9 and 14 exhibit strong cytotoxic activity, surpassing doxorubicin. Compounds 2, 6, 10 and 13 exhibited intermediate activity, while compounds 3, 7 and 12 had minimal effects. Docking studies suggest potential ADORA1 receptor interaction. Computational tools analyze stability and interaction with biological systems, revealing potential antitumor mechanisms.Conclusion: Green synthesis of diverse heterocycles yielded potent antitumor agents (compounds 9 & 14). DFT and Docking studies suggest interaction with ADORA1 receptor, a potential mechanism.

目的:本研究以一种哌啶基化合物(1)为原料,以生态友好的方式合成了多种杂环化合物,并探索了它们作为抗肿瘤药物的潜力:材料与方法:利用超声波辐照合成吡啶酮、噻吩和香豆素等杂环化合物,并利用计算工具分析其稳定性和生物相互作用:结果:化合物 9 和 14 具有很强的细胞毒活性,超过了多柔比星。化合物 2、6、10 和 13 表现出中等活性,而化合物 3、7 和 12 的作用则微乎其微。对接研究表明,这些化合物可能与 ADORA1 受体相互作用。计算工具分析了化合物的稳定性以及与生物系统的相互作用,揭示了潜在的抗肿瘤机制:多种杂环化合物的绿色合成产生了有效的抗肿瘤药物(化合物 9 和 14)。DFT 和 Docking 研究表明,与 ADORA1 受体的相互作用是一种潜在机制。
{"title":"Ultrasonic-assisted synthesis and antitumor evaluation of novel variant heterocyclic compounds based on piperidine ring.","authors":"Asmaa Aboelnaga, Eman El-Sayed Ebead, Ekhlass Nassar, Mohamed M Naguib, Mahmoud F Ismail","doi":"10.1080/17568919.2024.2385295","DOIUrl":"https://doi.org/10.1080/17568919.2024.2385295","url":null,"abstract":"<p><p><b>Aim:</b> This work explores the eco-friendly synthesis of various heterocycles from a piperidine-based compound (<b>1</b>) and explore their potential as antitumor agents.<b>Materials & methods:</b> Ultrasonic irradiation was used to synthesize heterocycles like pyridone, thiophene and coumarin, with computational tools analyzing stability and biological interactions.<b>Results:</b> Compounds <b>9</b> and <b>14</b> exhibit strong cytotoxic activity, surpassing doxorubicin. Compounds <b>2</b>, <b>6</b>, <b>10</b> and <b>13</b> exhibited intermediate activity, while compounds <b>3</b>, <b>7</b> and <b>12</b> had minimal effects. Docking studies suggest potential ADORA1 receptor interaction. Computational tools analyze stability and interaction with biological systems, revealing potential antitumor mechanisms.<b>Conclusion:</b> Green synthesis of diverse heterocycles yielded potent antitumor agents (compounds <b>9</b> & <b>14</b>). DFT and Docking studies suggest interaction with ADORA1 receptor, a potential mechanism.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structure-activity relationships study of N-ethylene glycol-comprising alkyl heterocyclic carboxamides against A549 lung cancer cells. 含 N-乙二醇的烷基杂环羧酰胺对 A549 肺癌细胞的结构-活性关系研究
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-19 DOI: 10.1080/17568919.2024.2394016
Kaito Ohta, Hiromi Ii, Mei Takahashi, Chiami Moyama, Shota Ando, Masaya Mori, Maho Masuda, Hisanori Nambu, Susumu Nakata, Naoto Kojima

Aim: Certain cancer cells depend on oxidative phosphorylation for survival; thus, inhibiting this process may be a promising treatment strategy. This study explored the structure-activity relationships of the mitochondrial inhibitor N-ethylene glycol-comprising alkyl thiophene-3-carboxamide 3.Methods & results: We synthesized and evaluated 13 analogs (5a-m) with different ethylene glycol units, heterocycles and connecting groups for their growth-inhibitory effects on A549 non-small cell lung cancer cells. We found that increasing the number of ethylene glycol units significantly enhanced inhibitory activity. Some analogs activated adenosine monophosphate-activated protein kinase, similar to 3. Notably, analog 5e, which contains tetraethylene glycol units, significantly inhibited tumor growth in vivo.Conclusion: Analog 5 may be a potential therapeutic agent for non-small cell lung cancer treatment.

目的:某些癌细胞的存活依赖于氧化磷酸化;因此,抑制这一过程可能是一种很有前景的治疗策略。本研究探讨了线粒体抑制剂 N-乙二醇-含烷基噻吩-3-甲酰胺 3 的结构-活性关系:我们合成并评估了13种具有不同乙二醇单元、杂环和连接基团的类似物(5a-m)对A549非小细胞肺癌细胞的生长抑制作用。我们发现,增加乙二醇单元的数量可显著增强抑制活性。一些类似物激活了单磷酸腺苷激活的蛋白激酶,与 3 类似。值得注意的是,含有四甘醇单位的类似物 5e 能显著抑制体内肿瘤的生长:结论:类似物 5 可能是治疗非小细胞肺癌的潜在药物。
{"title":"Structure-activity relationships study of <i>N</i>-ethylene glycol-comprising alkyl heterocyclic carboxamides against A549 lung cancer cells.","authors":"Kaito Ohta, Hiromi Ii, Mei Takahashi, Chiami Moyama, Shota Ando, Masaya Mori, Maho Masuda, Hisanori Nambu, Susumu Nakata, Naoto Kojima","doi":"10.1080/17568919.2024.2394016","DOIUrl":"https://doi.org/10.1080/17568919.2024.2394016","url":null,"abstract":"<p><p><b>Aim:</b> Certain cancer cells depend on oxidative phosphorylation for survival; thus, inhibiting this process may be a promising treatment strategy. This study explored the structure-activity relationships of the mitochondrial inhibitor <i>N</i>-ethylene glycol-comprising alkyl thiophene-3-carboxamide <b>3</b>.<b>Methods & results:</b> We synthesized and evaluated 13 analogs (<b>5a</b>-<b>m</b>) with different ethylene glycol units, heterocycles and connecting groups for their growth-inhibitory effects on A549 non-small cell lung cancer cells. We found that increasing the number of ethylene glycol units significantly enhanced inhibitory activity. Some analogs activated adenosine monophosphate-activated protein kinase, similar to <b>3</b>. Notably, analog <b>5e</b>, which contains tetraethylene glycol units, significantly inhibited tumor growth <i>in vivo</i>.<b>Conclusion:</b> Analog <b>5</b> may be a potential therapeutic agent for non-small cell lung cancer treatment.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benzimidazole-acrylonitrile hybrid derivatives act as potent urease inhibitors with possible fungicidal activity. 苯并咪唑-丙烯腈杂化衍生物是一种有效的脲酶抑制剂,可能具有杀菌活性。
IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-09-19 DOI: 10.1080/17568919.2024.2393570
Ebrahim Saeedian Moghadam, Abdullah Mohammed Al-Sadi, Mahdis Sadeghi Moghadam, Bahareh Bayati, Meysam Talebi, Massoud Amanlou, Mohsen Amini, Raid Abdel-Jalil

Aim: A series of benzimidazole-acrylonitrile derivatives TM1-TM53 were designed with urease inhibition approach.Materials & methods: TM1-TM53 were synthesized and characterized (1H Nuclear Magnetic Resonance (NMR), 13C NMR, Mass Spectroscopy (MS) and IR) and subjected to urease inhibition assay using commercial assay kit. A molecular docking study was also performed using Autodock tool software.Results: Except six compounds, target molecules exhibited a higher urease inhibition effect (IC50: 1.22-28.45 μM) than hydroxyurea (IC50: 100 μM). kinetic study on TM11, clarified its mode of action as a mixed inhibitor. A molecular docking study on TM6, TM11 and TM21, was performed and the results showed the main residues inside the active site of the enzyme. All TM1-TM53 were also studied in silico using molecular docking techniques to evaluate their potential to inhibit succinate dehydrogenase in comparison to fluxapyroxad as standard. Docking study revealed the high potential of TM1-TM53 as a fungicides.Conclusion: Obtained results exhibited the high activity of benzimidazole-acrylonitrile derivatives as urease inhibitors and their possible potential as fungicide agents. So, it will be beneficial to do more bioactivity investigation on this family of compounds.

目的:采用脲酶抑制方法设计了一系列苯并咪唑-丙烯腈衍生物 TM1-TM53:对 TM1-TM53 进行了合成和表征(1H 核磁共振 (NMR)、13C NMR、质谱 (MS) 和红外光谱),并使用商业检测试剂盒进行了尿素酶抑制试验。此外,还使用 Autodock 工具软件进行了分子对接研究:对 TM11 进行的动力学研究明确了其作为混合抑制剂的作用模式。对 TM6、TM11 和 TM21 进行了分子对接研究,结果显示了酶活性位点内的主要残基。此外,还利用分子对接技术对所有 TM1-TM53 进行了硅学研究,以评估它们与标准品氟沙吡啶相比抑制琥珀酸脱氢酶的潜力。对接研究表明,TM1-TM53 具有很高的杀菌潜力:结论:研究结果表明,苯并咪唑-丙烯腈衍生物作为脲酶抑制剂具有很高的活性,并具有作为杀真菌剂的潜力。因此,对这一系列化合物进行更多的生物活性研究将是有益的。
{"title":"Benzimidazole-acrylonitrile hybrid derivatives act as potent urease inhibitors with possible fungicidal activity.","authors":"Ebrahim Saeedian Moghadam, Abdullah Mohammed Al-Sadi, Mahdis Sadeghi Moghadam, Bahareh Bayati, Meysam Talebi, Massoud Amanlou, Mohsen Amini, Raid Abdel-Jalil","doi":"10.1080/17568919.2024.2393570","DOIUrl":"https://doi.org/10.1080/17568919.2024.2393570","url":null,"abstract":"<p><p><b>Aim:</b> A series of benzimidazole-acrylonitrile derivatives <b>TM1-TM53</b> were designed with urease inhibition approach.<b>Materials & methods:</b> <b>TM1-TM53</b> were synthesized and characterized (<sup>1</sup>H Nuclear Magnetic Resonance (NMR), <sup>13</sup>C NMR, Mass Spectroscopy (MS) and IR) and subjected to urease inhibition assay using commercial assay kit. A molecular docking study was also performed using Autodock tool software.<b>Results:</b> Except six compounds, target molecules exhibited a higher urease inhibition effect (IC<sub>50</sub>: 1.22-28.45 μM) than hydroxyurea (IC<sub>50</sub>: 100 μM). kinetic study on <b>TM11</b>, clarified its mode of action as a mixed inhibitor. A molecular docking study on <b>TM6</b>, <b>TM11</b> and <b>TM21</b>, was performed and the results showed the main residues inside the active site of the enzyme. All <b>TM1-TM53</b> were also studied <i>in silico</i> using molecular docking techniques to evaluate their potential to inhibit succinate dehydrogenase in comparison to fluxapyroxad as standard. Docking study revealed the high potential of <b>TM1-TM53</b> as a fungicides.<b>Conclusion:</b> Obtained results exhibited the high activity of benzimidazole-acrylonitrile derivatives as urease inhibitors and their possible potential as fungicide agents. So, it will be beneficial to do more bioactivity investigation on this family of compounds.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Future medicinal chemistry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1